Utilising mRNA's versatility to elicit potent immune responses against cancer, these vaccines can prompt the immune system to recognise and eliminate cancer cells displaying these antigens, writes Dr Praveen Kumar Kaudlay
Praveen Kumar is an Assistant Editor who writes for a diverse range of publications, including LiveMint, IEEE, Deccan Herald, and many more. With a focus on technology, science, and innovation, Praveen's work covers topics such as artificial intelligence, renewable energy, nanotechnology, and legal implications of technological advancements.